Skip to main content
Premium Trial:

Request an Annual Quote

Law Firms Investigating Monogram Over LabCorp Deal

NEW YORK (GenomeWeb News) – A few law firms have announced that they are investigating Monogram Biosciences' board of directors for possible breach of fiduciary duty following the firm's announcement yesterday that it has signed a definitive agreement to be acquired by Laboratory Corporation of America for around $107 million.

The law firms — Levi & Korsinsky; Brodsky & Smith; and Howard G. Smith — suggested that the price of the acquisition may not be fair to Monogram's shareholders.

The deal calls for LabCorp to pay Monogram's shareholders $4.55 per share, which is a significant premium over the firm's closing price of $1.68 on the Nasdaq the day before the transaction was announced. However, Monogram's shares traded at the equivalent of $7.20 in August 2008, adjusting for a 6-for-1 reverse stock split in November, according to the law firms.

Monogram and LabCorp hope to close the deal in the third quarter.

Monogram officials did not return a call seeking comment by the tiem this article was published.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.